Clean Science & Technology Grants 5,000 Employee Stock Options at Rs.500 Exercise Price Under ESOP Scheme 2021

Clean Science & Technology 's Nomination and Remuneration Committee (NRC) approved the grant of 5,000 Employee Stock Options (ESOPs) to eligible employees on Thursday, May 14, 2026. The grant was made under the Clean Science and Technology Limited Employee Stock Option Scheme 2021 (CSTL ESOS 2021), in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI (Share Based Employee Benefit and Sweat Equity) Regulations, 2021. The company disclosed this development to both BSE Limited and the National Stock Exchange of India Limited.

Key Details of the ESOP Grant

The following table summarises the core parameters of the stock option grant approved by the NRC:

Parameter: Details Number of Options Granted: 5,000 (Five Thousand) Stock Options Scheme Name: Clean Science and Technology Limited Employee Stock Option Scheme 2021 Equity Shares Covered: 5,000 (Five Thousand) Equity Shares Face Value per Share: Re. 1/- each Exercise Price: Rs.500/- (Rupees Five Hundred Only) per option Conversion Ratio: Each Stock Option is convertible into One (1) Equity Share SEBI Compliance: Yes — SEBI (Share Based Employee Benefit and Sweat Equity) Regulations, 2021

Vesting Schedule

The 5,000 stock options are subject to a four-year vesting schedule. The vesting is structured progressively, with a larger portion vesting in the final year. The detailed vesting schedule is as follows:

Date of Vesting: Vesting Percentage 14.05.2027 20% of options granted 14.05.2028 20% of options granted 14.05.2029 20% of options granted 14.05.2030 40% of options granted

The exercise period for each tranche is 1 (one) year from the respective date of vesting. This means eligible employees must exercise their vested options within one year of each vesting date.

Scheme Administration and Eligibility

The CSTL ESOS 2021 is administered by the Nomination and Remuneration Committee. The grant of stock options is based on the eligibility criteria as specified under the CSTL ESOS 2021 scheme. The company has confirmed that no options have been exercised, lapsed, or cancelled in connection with this grant, and there are no variations to the terms of the options at this stage.

The intimation was signed by Ruchita Vij, Company Secretary and Compliance Officer of Clean Science & Technology, and submitted to the stock exchanges on May 14, 2026.

Clean Science & Technology reported its audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. The company's standalone profit after tax (PAT) for the year stood at ₹2,512.17 million, a decrease from ₹2,923.02 million in the previous year. Revenue from operations for the year declined to ₹8,153.35 million compared to ₹9,223.16 million in FY25. The Board of Directors, at their meeting held on May 14, 2026, approved the audited financial results and recommended a final dividend of ₹4 per equity share for the financial year ended March 31, 2026, subject to shareholder approval at the ensuing Annual General Meeting.

Standalone Financial Performance

For the quarter ended March 31, 2026, the company recorded a standalone PAT of ₹581.21 million, down from ₹786.08 million in the corresponding quarter of the previous year. Revenue from operations for the quarter was ₹1,971.30 million, lower than ₹2,453.86 million in Q4 FY25. Total income for the quarter stood at ₹1,972.91 million. Notably, during the quarter, the Executive Directors voluntarily elected to forgo a substantial portion of their performance bonus entitlement for FY26, resulting in a reversal of previously recognised provisions and lower employee benefits expense for the quarter compared to the quarter ended December 31, 2025.

The following table summarises the standalone financial results for the year:

Metric: FY26 (Audited) FY25 (Audited) Revenue from operations: ₹8,153.35 million ₹9,223.16 million Total income: ₹8,428.39 million ₹9,584.99 million Total expenses: ₹5,072.28 million ₹5,679.49 million Profit before tax: ₹3,356.11 million ₹3,905.50 million Profit after tax: ₹2,512.17 million ₹2,923.02 million Basic EPS (₹): ₹23.64 ₹27.51

Consolidated Financial Performance

On a consolidated basis, the company reported a PAT of ₹2,296.55 million for FY26, compared to ₹2,644.05 million in the previous year. Consolidated revenue from operations for the year was ₹9,565.47 million, a marginal decrease from ₹9,666.44 million in FY25. For the quarter ended March 31, 2026, consolidated PAT was ₹582.72 million on revenue from operations of ₹2,492.53 million, compared to ₹740.92 million PAT on revenue of ₹2,636.83 million in Q4 FY25.

The following table summarises the consolidated financial results for the year:

Metric: FY26 (Audited) FY25 (Audited) Revenue from operations: ₹9,565.47 million ₹9,666.44 million Total income: ₹9,891.02 million ₹10,052.31 million Total expenses: ₹6,794.32 million ₹6,485.00 million Profit before tax: ₹3,096.70 million ₹3,567.31 million Profit after tax: ₹2,296.55 million ₹2,644.05 million Basic EPS (₹): ₹21.61 ₹24.88

Standalone Balance Sheet Highlights

As at March 31, 2026, total standalone assets stood at ₹17,839.51 million compared to ₹16,048.84 million as at March 31, 2025. Total equity increased to ₹16,456.44 million from ₹14,567.28 million. Cash and cash equivalents at the standalone level stood at ₹174.23 million at year-end, up from ₹148.16 million. During the year, 10,040 equity shares of ₹1 each fully paid-up were allotted upon exercise of vested stock options pursuant to the Company's Employee Stock Option Scheme, 2021 (ESOP 2021).

Board Decisions

In addition to approving the financial results and recommending the final dividend, the Board approved an additional investment of ₹200 Crores in one or more tranches in Clean Fino-Chem Limited, a wholly owned subsidiary. The Board also approved the re-appointment of M/s CNK JBMS & Associates as Internal Auditors and M/s Dhananjay V. Joshi & Associates as Cost Auditors for FY 2026-27. The book closure and dividend payment date will be determined later.

Board Decision: Details Final Dividend: ₹4 per equity share (face value ₹1) for FY26 Subsidiary Investment: ₹200 Crores in Clean Fino-Chem Limited (one or more tranches) Internal Auditors (FY27): M/s CNK JBMS & Associates Cost Auditors (FY27): M/s Dhananjay V. Joshi & Associates

Audit Opinion

The statutory auditors, Price Waterhouse Chartered Accountants LLP, issued an audit report with an unmodified opinion on both the standalone and consolidated financial results for the year ended March 31, 2026. The consolidated results include four wholly owned subsidiaries: Clean Fino-Chem Limited, Clean Science Private Limited, Clean Aromatics Private Limited, and Clean Organics Private Limited. The Group is exclusively engaged in the manufacturing of organic chemicals, constituting a single primary business segment.

Source: None/Company/INE227W01023/31e52005-a7d1-49e0-be35-870fb0fc9f6a.pdf

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.